Cargando…

Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19

The importance of host genetics and demography in coronavirus disease 2019 (COVID-19) is a crucial aspect of infection, prognosis and associated case fatality rate. Individual genetic landscapes can contribute to understand Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) burden and can...

Descripción completa

Detalles Bibliográficos
Autores principales: Gemmati, Donato, Tisato, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563402/
https://www.ncbi.nlm.nih.gov/pubmed/32899439
http://dx.doi.org/10.3390/genes11091044
_version_ 1783595481636536320
author Gemmati, Donato
Tisato, Veronica
author_facet Gemmati, Donato
Tisato, Veronica
author_sort Gemmati, Donato
collection PubMed
description The importance of host genetics and demography in coronavirus disease 2019 (COVID-19) is a crucial aspect of infection, prognosis and associated case fatality rate. Individual genetic landscapes can contribute to understand Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) burden and can give information on how to fight virus spreading and the associated severe acute respiratory distress syndrome (ARDS). The spread and pathogenicity of the virus have become pandemic on specific geographic areas and ethnicities. Interestingly, SARS-CoV-2 firstly emerged in East Asia and next in Europe, where it has caused higher morbidity and mortality. This is a peculiar feature of SARS-CoV-2, different from past global viral infections (i.e., SARS-1 or MERS); it shares with the previous pandemics strong age- and sex-dependent gaps in the disease outcome. The observation that the severest COVID-19 patients are more likely to have a history of hypertension, diabetes and/or cardiovascular disease and receive Renin-Angiotensin-System (RAS) inhibitor treatment raised the hypothesis that RAS-unbalancing may have a crucial role. Accordingly, we recently published a genetic hypothesis on the role of RAS-pathway genes (ACE1, rs4646994, rs1799752, rs4340, rs13447447; and ACE2, rs2285666, rs1978124, rs714205) and ABO-locus (rs495828, rs8176746) in COVID-19 prognosis, suspecting inherited genetic predispositions to be predictive of COVID-19 severity. In addition, recently, Genome-Wide Association Studies (GWAS) found COVID-19-association signals at locus 3p21.31 (rs11385942) comprising the solute carrier SLC6A20 (Na+ and Cl- coupled transporter family) and at locus 9q34.2 (rs657152) coincident with ABO-blood group (rs8176747, rs41302905, rs8176719), and interestingly, both loci are associated to RAS-pathway. Finally, ACE1 and ACE2 haplotypes seem to provide plausible explanations for why SARS-CoV-2 have affected more heavily some ethnic groups, namely people with European ancestry, than Asians.
format Online
Article
Text
id pubmed-7563402
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75634022020-10-27 Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19 Gemmati, Donato Tisato, Veronica Genes (Basel) Hypothesis The importance of host genetics and demography in coronavirus disease 2019 (COVID-19) is a crucial aspect of infection, prognosis and associated case fatality rate. Individual genetic landscapes can contribute to understand Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) burden and can give information on how to fight virus spreading and the associated severe acute respiratory distress syndrome (ARDS). The spread and pathogenicity of the virus have become pandemic on specific geographic areas and ethnicities. Interestingly, SARS-CoV-2 firstly emerged in East Asia and next in Europe, where it has caused higher morbidity and mortality. This is a peculiar feature of SARS-CoV-2, different from past global viral infections (i.e., SARS-1 or MERS); it shares with the previous pandemics strong age- and sex-dependent gaps in the disease outcome. The observation that the severest COVID-19 patients are more likely to have a history of hypertension, diabetes and/or cardiovascular disease and receive Renin-Angiotensin-System (RAS) inhibitor treatment raised the hypothesis that RAS-unbalancing may have a crucial role. Accordingly, we recently published a genetic hypothesis on the role of RAS-pathway genes (ACE1, rs4646994, rs1799752, rs4340, rs13447447; and ACE2, rs2285666, rs1978124, rs714205) and ABO-locus (rs495828, rs8176746) in COVID-19 prognosis, suspecting inherited genetic predispositions to be predictive of COVID-19 severity. In addition, recently, Genome-Wide Association Studies (GWAS) found COVID-19-association signals at locus 3p21.31 (rs11385942) comprising the solute carrier SLC6A20 (Na+ and Cl- coupled transporter family) and at locus 9q34.2 (rs657152) coincident with ABO-blood group (rs8176747, rs41302905, rs8176719), and interestingly, both loci are associated to RAS-pathway. Finally, ACE1 and ACE2 haplotypes seem to provide plausible explanations for why SARS-CoV-2 have affected more heavily some ethnic groups, namely people with European ancestry, than Asians. MDPI 2020-09-03 /pmc/articles/PMC7563402/ /pubmed/32899439 http://dx.doi.org/10.3390/genes11091044 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Hypothesis
Gemmati, Donato
Tisato, Veronica
Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
title Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
title_full Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
title_fullStr Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
title_full_unstemmed Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
title_short Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
title_sort genetic hypothesis and pharmacogenetics side of renin-angiotensin-system in covid-19
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563402/
https://www.ncbi.nlm.nih.gov/pubmed/32899439
http://dx.doi.org/10.3390/genes11091044
work_keys_str_mv AT gemmatidonato genetichypothesisandpharmacogeneticssideofreninangiotensinsystemincovid19
AT tisatoveronica genetichypothesisandpharmacogeneticssideofreninangiotensinsystemincovid19